EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 201 filers reported holding EDITAS MEDICINE INC in Q1 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $629,656 | +2.9% | 134,830 | +63.4% | 0.00% | – |
Q1 2024 | $612,150 | -26.8% | 82,500 | 0.0% | 0.00% | – |
Q4 2023 | $835,725 | +29.9% | 82,500 | 0.0% | 0.00% | – |
Q3 2023 | $643,500 | -9.7% | 82,500 | -4.7% | 0.00% | – |
Q2 2023 | $712,718 | +19.2% | 86,600 | +5.0% | 0.00% | – |
Q1 2023 | $598,125 | -18.3% | 82,500 | 0.0% | 0.00% | – |
Q4 2022 | $731,775 | -27.5% | 82,500 | 0.0% | 0.00% | – |
Q3 2022 | $1,010,000 | +3.5% | 82,500 | 0.0% | 0.00% | – |
Q2 2022 | $976,000 | -37.8% | 82,500 | -0.0% | 0.00% | -100.0% |
Q1 2022 | $1,569,000 | -28.2% | 82,504 | +0.2% | 0.00% | 0.0% |
Q4 2021 | $2,185,000 | -35.4% | 82,304 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $3,381,000 | -27.5% | 82,304 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $4,662,000 | +34.9% | 82,304 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $3,457,000 | -39.7% | 82,304 | +0.6% | 0.00% | -33.3% |
Q4 2020 | $5,735,000 | +149.9% | 81,800 | 0.0% | 0.00% | +200.0% |
Q3 2020 | $2,295,000 | -4.7% | 81,800 | +0.5% | 0.00% | 0.0% |
Q2 2020 | $2,408,000 | +78.4% | 81,400 | +19.5% | 0.00% | 0.0% |
Q1 2020 | $1,350,000 | -32.4% | 68,100 | +1.0% | 0.00% | 0.0% |
Q4 2019 | $1,996,000 | +32.6% | 67,400 | +1.8% | 0.00% | 0.0% |
Q3 2019 | $1,505,000 | -8.1% | 66,200 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $1,638,000 | +1.2% | 66,200 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $1,619,000 | -42.9% | 66,200 | -46.9% | 0.00% | -50.0% |
Q4 2018 | $2,835,000 | +36.0% | 124,600 | +90.2% | 0.00% | +100.0% |
Q3 2018 | $2,084,000 | -10.0% | 65,500 | +1.4% | 0.00% | -50.0% |
Q2 2018 | $2,315,000 | -17.5% | 64,600 | -23.7% | 0.00% | 0.0% |
Q1 2018 | $2,807,000 | +114.4% | 84,670 | +98.8% | 0.00% | +100.0% |
Q4 2017 | $1,309,000 | +30.8% | 42,600 | +2.2% | 0.00% | 0.0% |
Q3 2017 | $1,001,000 | +43.0% | 41,700 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $700,000 | +29.6% | 41,700 | +72.3% | 0.00% | – |
Q1 2017 | $540,000 | +37.4% | 24,200 | 0.0% | 0.00% | – |
Q4 2016 | $393,000 | +20.6% | 24,200 | 0.0% | 0.00% | – |
Q3 2016 | $326,000 | -19.5% | 24,200 | +45.8% | 0.00% | – |
Q2 2016 | $405,000 | – | 16,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 185,668 | $5,908,000 | 4.56% |
ARK Investment Management | 2,793,854 | $88,900,000 | 2.69% |
Elmwood Wealth Management, Inc. | 94,067 | $2,993,212,000 | 2.48% |
JS Capital Management LLC | 218,935 | $6,967,000 | 1.92% |
Casdin Capital, LLC | 460,000 | $14,637,000 | 1.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,158,841 | $36,874,000 | 1.32% |
Valiant Capital Management, L.P. | 379,800 | $12,085,000 | 1.07% |
Castle Rock Wealth Management, LLC | 16,315 | $442,000 | 0.70% |
Capital Impact Advisors, LLC | 57,406 | $1,861,000 | 0.64% |
Global Thematic Partners, LLC | 481,568 | $15,323,000 | 0.60% |